logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yilei Mao

Peking Union Medical College Hospital
H指数:46
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy

患者来源的3D生物打印肝内胆管癌模型重现肿瘤自体特性并预测个性化辅助治疗

Advanced Science
IF14.1
2026-02-080
OAAI
Yuce Lu; Liwei Du; Minghao Sun; Kai Zhang; Mingchang Pang; Shangze Jiang; Jiaxun Dong; Xiyue Liu; Bao Jin; Fu Xu; Hang Sun; Jiangang Zhang; Huiyu Yang; Xiaobo Yang; Xin Lu; Yiyao Xu; Haitao Zhao; Shunda Du; Xinting Sang; Yongchang Zheng; Lei Zhang; Xueshuai Wan; Huayu Yang; Yilei Mao
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study

基于免疫疗法的策略与经导管动脉化疗栓塞的比较及治疗持续时间对伴有微血管侵犯的肝细胞癌的影响：一项回顾性多中心队列研究

Journal of Hepatocellular Carcinoma
IF3.4
2025-10-210
OAAI
Xiaokun Chen; Jiali Xing; Baoluhe Zhang; Wei Peng; Ziyue Huang; Taifeng Zhu; Liguo Liu; Xiao Liu; Xueshuai Wan; Yilei Mao; Xiaoyan Chang; Kang Zhou; Jie Pan; Dandan Hu; Haidong Tan; Yaojun Zhang; Mei Guan; Shunda Du
Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models

使用患者衍生的3D生物打印胃癌模型探索临床化疗疗效的个性化预测和揭示肿瘤异质性

Molecular Cancer
IF33.9
2025-10-160
OAAI
Liwei Du; Zicheng Zheng; Kai Zhang; Hang Sun; Yuce Lu; Minghao Sun; Mingchang Pang; Shangze Jiang; Yixuan He; Shunda Du; Haitao Zhao; Yilei Mao; Weiming Kang; Penglei Ge; Huayu Yang
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021

可归因于代谢风险的原发性肝癌的全球，区域和国家负担: 对1990-2021全球疾病负担研究的分析

AMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
2025-10-017
PRE
Wu, Chutian; Targher, Giovanni; Byrne, Christopher D.; Mao, Yilei; Cheung, Tan To; Yilmaz, Yusuf; Valenti, Luca; Mendez-Sanchez, Nahum; Sookoian, Silvia; Chan, Wah-Kheong; Treeprasertsuk, Sombat; Yu, Hon Ho; Kim, Seung Up; George, Jacob; Hu, Dandan; Sebastiani, Giada; Ryan, John D.; Oviedo, Rodolfo J.; Zhong, Jian-Hong; Schattenberg, Jorn M.; Lonardo, Amedeo; Ruiz-Ucar, Elena; Seto, Wai-Kay; Sotoudeheian, Mohammadjavad; Ocama, Ponsiano; Lupsor-Platon, Monica; Yang, Tian; Ghazinyan, Hasmik; Pan, Qiuwei; Hamid, Saeed; Adams, Leon; Chai, Jin; Prasad, Arun; Perera, Nilanka; Alswat, Khalid; Isakov, Vasily; Sarin, Shiv Kumar; Sharara, Ala I.; Sanai, Faisal M.; Al-Busafi, Said A.; Opio, Christopher Kenneth; Toro-Huamanchumo, Carlos Jesus; Yang, Wah; Wong, Yu Jun; Torzilli, Guido; Fouad, Yasser; Zheng, Ming-Hua
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

托瑞帕利马布联合贝伐珠单抗对比索拉非尼作为晚期肝细胞癌的一线治疗（HEPATORCH）：一项随机、开放标签、III期试验

The Lancet Gastroenterology & Hepatology
IF0
2025-05-200
PRE
Yinghong Shi; Guohong Han; Jian Zhou; Xuetao Shi; Weidong Jia; Ying Cheng; Yongdong Jin; Xiangdong Hua; Tianfu Wen; Jianbing Wu; Shanzhi Gu; Yuxian Bai; Xiangcai Wang; Tao Zhang; Zhiyu Chen; Bixiang Zhang; Ming Huang; Hongming Liu; Yilei Mao; Ledu Zhou; Jia Fan

研究方向

暂未获取到该数据
H
Huayu Yang
H 指数:37论文数:264被引数:5,194
X
Xinting Sang
H 指数:44论文数:326被引数:6,775
H
Haitao Zhao
H 指数:58论文数:555被引数:1.4万
S
Shunda Du
H 指数:25论文数:220被引数:2,584
L
Lejia Sun
H 指数:21论文数:76被引数:1,670
B
Bao Jin
H 指数:18论文数:72被引数:1,072
S
Shouxian Zhong
H 指数:24论文数:123被引数:2,388
G
Gang Xu
H 指数:30论文数:139被引数:2,679
X
Xin Lu
H 指数:29论文数:166被引数:3,372
H
Haifeng Xu
H 指数:19论文数:141被引数:1,552